Absci Corporation (ABSI) vs MannKind Corporation (MNKD)
- Absci Corporation ABSI 7.58 +1.34%
- MannKind Corporation MNKD 4.07 +2.78%
Absci Corporation and MannKind Corporation are both Biotechnology companies. Absci Corporation and MannKind Corporation are of similar size ($1.3B and $1.3B). MannKind Corporation grew revenue faster over the last twelve months: 31.7% against −47.2%. MannKind Corporation has the higher net margin (−18.1% vs −8,451.3%) and the higher return on invested capital (−2.58% vs −182.0%). Across the 17 metrics below, MannKind Corporation leads on 13 and Absci Corporation on 4.
Valuation
Profitability
| Metric | ABSI | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.76% | 70.18% |
| Operating margin | (8,812.31%) | (2.88%) | 0.00% |
| Net margin | (8,451.31%) | (18.10%) | 0.00% |
| Free cash flow margin | (7,550.91%) | (18.97%) | 0.00% |
| Return on equity | (58.59%) | 182.90% | (50.72%) |
| Return on assets | (51.87%) | (12.29%) | (45.56%) |
| Return on invested capital | (181.96%) | (2.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack